Korean Market
EXCH
CHONGKUNDANG HOLDINGS
★

Chongkundang Holdings: 2025 Operating Profit Surges 64%, Zero-Coupon Exchangeable Bonds Improve Financial Structure; Dividend Maintained for 22 Consecutive Years

 
EXCH
CHONGKUNDANG HOLDINGS
★

Chongkundang Holdings' major shareholder stake marginally rises to 48.04% via open market purchases by affiliate; negligible impact on shareholder value

 
OWNR
CHONGKUNDANG HOLDINGS
★

Largest Shareholder Lee Jang-han Slightly Increases Stake to 48.04% via Open Market Purchase… Signal of Strengthened Management Control

 
PERI
CHONGKUNDANG HOLDINGS
★★

Chong Kun Dang Holdings: Q1 2026 Operating Profit Surges 62%... Dividend Income and R&D Milestones

 
EXCH
CHONGKUNDANG HOLDINGS
★

Chong Kun Dang Files Phase 3 IND for Hypertension Drug CKD-339

 
EXCH
CHONGKUNDANG HOLDINGS
★

Kyungbo Pharm Increases ADC Plant Investment to 96 Billion Won (66.49% of Equity)

 
EXCH
CHONGKUNDANG HOLDINGS
★

Chong Kun Dang 2025 Consolidated: Sales↑6.7%, Op.Profit↓19%, Net↓30.2%

 
EXCH
CHONGKUNDANG HOLDINGS
★★

Kyungbo Pharm: Revenue Up but Operating Profit Plunges 66%, Net Profit Down 98%